Physician profile
Gregory Crooke
NPI 1457351744
$6,426.45
in general payments reported to CMS, 2019-2025
11 companies · $2,479 in 2025
The $2,479 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,715 · 2020: $258 · 2021: $227 · 2022: $96.64 · 2023: $809 · 2024: $843 · 2025: $2,479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,033 · Travel and Lodging: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,032.55 |
| Travel and Lodging | $1,097.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,216.93 | 2019-2025 | Triclip, Thoratec Heartmate 3 Lvas Implant Kit, Navitor |
| Edwards Lifesciences Corporation | $2,013.38 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal, Mitris Resilia Mitral Valve |
| Medtronic Vascular, INC. | $1,204.13 | 2019 | |
| Atricure, INC. | $305.69 | 2022-2024 | |
| Medtronic, INC. | $300.43 | 2021-2025 | Corevalve Evolut R |
| Abiomed | $213.84 | 2025 | |
| Baxter Healthcare | $57.26 | 2023-2024 | Coseal, Preveleak |
| Ethicon US, LLC | $54.44 | 2019-2021 | |
| Fresenius USA Marketing, INC. | $25.72 | 2023 | Novalung System |
| Astrazeneca Pharmaceuticals Lp | $20.00 | 2019 | |
| Biomerieux INC | $14.63 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Crooke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.